Tarsus Pharmaceuticals, Inc. (TARS)
68.20
-3.88
(-5.38%)
USD |
NASDAQ |
Oct 23, 16:00
68.16
-0.04
(-0.06%)
After-Hours: 20:00
Tarsus Pharmaceuticals Market Cap : 2.951B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 2.951B |
| October 22, 2026 | 3.119B |
| October 21, 2026 | 3.051B |
| October 20, 2026 | 3.074B |
| October 19, 2026 | 3.007B |
| October 16, 2026 | 2.945B |
| October 15, 2026 | 3.072B |
| October 14, 2026 | 3.128B |
| October 13, 2026 | 3.064B |
| October 12, 2026 | 3.219B |
| October 09, 2026 | 3.166B |
| October 08, 2026 | 3.125B |
| October 07, 2026 | 3.185B |
| October 06, 2026 | 3.207B |
| October 05, 2026 | 3.222B |
| October 02, 2026 | 3.159B |
| October 01, 2026 | 3.265B |
| September 30, 2026 | 3.402B |
| September 29, 2026 | 3.318B |
| September 28, 2026 | 3.324B |
| September 25, 2026 | 3.275B |
| September 24, 2026 | 3.287B |
| September 23, 2026 | 3.215B |
| September 22, 2026 | 3.335B |
| September 21, 2026 | 3.352B |
| Date | Value |
|---|---|
| September 18, 2026 | 3.379B |
| September 17, 2026 | 3.420B |
| September 16, 2026 | 3.360B |
| September 15, 2026 | 3.385B |
| September 14, 2026 | 3.460B |
| September 11, 2026 | 3.432B |
| September 10, 2026 | 3.510B |
| September 09, 2026 | 3.582B |
| September 08, 2026 | 3.774B |
| September 04, 2026 | 3.928B |
| September 03, 2026 | 3.600B |
| September 02, 2026 | 3.581B |
| September 01, 2026 | 3.204B |
| August 31, 2026 | 3.212B |
| August 28, 2026 | 3.105B |
| August 27, 2026 | 3.112B |
| August 26, 2026 | 3.057B |
| August 25, 2026 | 3.092B |
| August 24, 2026 | 3.151B |
| August 21, 2026 | 3.146B |
| August 20, 2026 | 3.093B |
| August 19, 2026 | 3.178B |
| August 18, 2026 | 3.074B |
| August 17, 2026 | 3.056B |
| August 14, 2026 | 2.994B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Bristol Myers Squibb Co. | 125.60B |
| Amneal Pharmaceuticals, Inc. | 6.508B |
| ANI Pharmaceuticals, Inc. | 1.668B |
| Corcept Therapeutics, Inc. | 9.266B |
| Veru, Inc. | 38.19M |
Market Cap Related Metrics
| PS Ratio | 4.829 |
| Price to Book Value | 8.511 |
| Price to Free Cash Flow | 52.29 |
| Price | 68.20 |
| Earnings Yield | -1.58% |